Bio-Rad Laboratories (BIO) News Today $298.80 +5.13 (+1.75%) As of 12:49 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Earnest Partners LLC Sells 18,428 Shares of Bio-Rad Laboratories, Inc. $BIO5 hours ago | marketbeat.comCampbell & CO Investment Adviser LLC Purchases Shares of 6,443 Bio-Rad Laboratories, Inc. $BIOAugust 28 at 6:31 AM | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Sells 980 Shares of Bio-Rad Laboratories, Inc. $BIOAugust 27 at 4:26 AM | marketbeat.comBio-Rad Laboratories, Inc. $BIO Shares Bought by Invesco Ltd.August 27 at 3:30 AM | marketbeat.comBio-Rad Hosts Webinar on Digital PCR AdvancementsAugust 26 at 9:30 AM | tipranks.comBio-Rad's Management to Participate in Upcoming Investor ConferencesAugust 25, 2025 | businesswire.comCandriam S.C.A. Sells 20,243 Shares of Bio-Rad Laboratories, Inc. $BIOAugust 25, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Rating Lowered to Hold at Wall Street ZenAugust 24, 2025 | americanbankingnews.comQuantbot Technologies LP Acquires New Shares in Bio-Rad Laboratories, Inc. $BIOAugust 23, 2025 | marketbeat.comS&P 500 Futures Climb in Premarket Trading; Bio-Rad Labs B, Ubiquiti LeadAugust 22, 2025 | barrons.comEthic Inc. Purchases 2,067 Shares of Bio-Rad Laboratories, Inc. $BIOAugust 22, 2025 | marketbeat.comDimensional Fund Advisors LP Grows Stock Position in Bio-Rad Laboratories, Inc. $BIOAugust 21, 2025 | marketbeat.comTikvah Management LLC Trims Stock Position in Bio-Rad Laboratories, Inc. $BIOAugust 20, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Citigroup Inc.August 18, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 11,313 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)August 18, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Sector Gamma ASAugust 17, 2025 | marketbeat.comDeutsche Bank AG Sells 6,644 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)August 17, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 17, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Entropy Technologies LPAugust 16, 2025 | marketbeat.comPNC Financial Services Group Inc. Sells 5,152 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)August 13, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by QVIDTVM Management LLCAugust 12, 2025 | marketbeat.comASR Vermogensbeheer N.V. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 11, 2025 | marketbeat.com6,148 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Koss Olinger Consulting LLCAugust 10, 2025 | marketbeat.comMackenzie Financial Corp Has $401,000 Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 9, 2025 | marketbeat.comBio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give PauseAugust 7, 2025 | seekingalpha.comBio-Rad Reports Second-Quarter 2025 Financial ResultsAugust 7, 2025 | uk.finance.yahoo.comWestfield Capital Management Co. LP Sells 129,934 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)August 6, 2025 | marketbeat.comNatixis Advisors LLC Trims Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 6, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Down 4.1% - What's Next?August 5, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Position Boosted by XTX Topco LtdAugust 3, 2025 | marketbeat.comAvantax Advisory Services Inc. Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 3, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Given New $409.00 Price Target at Royal Bank Of CanadaAugust 2, 2025 | marketbeat.comWells Fargo & Company Increases Bio-Rad Laboratories (NYSE:BIO) Price Target to $265.00August 2, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Gap Up on Strong EarningsAugust 2, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Buys 5,852 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)August 2, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Raised to "Buy" at Wall Street ZenAugust 2, 2025 | marketbeat.comBio-Rad Laboratories Inc (BIO) Q2 2025: Everything You Need To Know Ahead Of EarningsAugust 1, 2025 | finance.yahoo.comBio-Rad (BIO) Q2 EPS Jumps 51%August 1, 2025 | fool.comBio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 EarningsAugust 1, 2025 | benzinga.comBio-Rad Laboratories Analysts Raise Their Forecasts After Better-Than-Expected Q2 EarningsAugust 1, 2025 | benzinga.comFederated Hermes Inc. Raises Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)August 1, 2025 | marketbeat.comBio-Rad Laboratories Inc (BIO) Q2 2025 Earnings Call Highlights: Navigating Growth Amidst ChallengesAugust 1, 2025 | gurufocus.comBio-Rad raises 2025 life science guidance to flat to 1% growth and expands ddPCR portfolio following Stilla acquisitionAugust 1, 2025 | msn.comQ2 2025 Bio Rad Laboratories Inc Earnings Call TranscriptJuly 31, 2025 | gurufocus.comBio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comBio-Rad Laboratories, Inc. 2025 Q2 - Results - Earnings Call PresentationJuly 31, 2025 | seekingalpha.comBio-Rad Laboratories (BIO) Surges 12.4% Following Earnings ReportJuly 31, 2025 | gurufocus.comBio-Rad Labs soars after significant earnings beatJuly 31, 2025 | in.investing.comBio-Rad Shares Rise 15% After Company Swings to Gain in 2QJuly 31, 2025 | marketwatch.comAssetmark Inc. Acquires 1,242 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)July 31, 2025 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.211.03▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼117▲BIO Articles Average Week Get the Latest News and Ratings for BIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access